This is a working overview of albumin binding, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-05. Anything still debated is marked as such rather than presented as settled.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
There is much research currently underway looking at ways to protect the nerve (neuroprotection) or even regenerate new fibers within the optic nerve. So far there is no evidence in human studies that the so-called neuroprotectors have any beneficial effect in NAION. However, there is a new current clinical trial for the treatment of NAION in the United States with plans to include sites in India, Israel, Germany and Australia (see NORDICclinicaltrials.com and https://clinicaltrials.gov/). This trial will test the use of a synthetic siRNA that blocks caspase 2, an important enzyme in the apoptosis cycle. In addition to such research, patents have been applied for by Pfizer, The University of Southern California, Otsuka Pharmaceutical and other individual inventors for innovations related to the treatment of anterior ischemic optic neuropathy. In recent years, pentoxifylline has emerged as a potential treatment option for NAION and other diseases involving ocular ischemia. Pentoxifylline has been shown to reduce erythrocyte rigidity, resulting in decreased blood viscosity and increased flow velocity. Animal studies have demonstrated that pentoxifylline can inhibit TNF and, in turn, prevent retinal ganglion cell death and axonal degeneration associated with optic neuropathy in a dose-dependent manner.
=== Monitor/recorder === The flow cells are connected to a display and/or recorder. On older systems this was a simple chart recorder, on modern systems a computer with hardware interface and display is used. This permits the experimenter to identify when peaks in protein concentration occur, indicating that specific components of the mixture are being eluted.
While there is limited literature on radiation injury to animals, there is no evidence of other types of radiation injury. Diagnostic radiation has been shown to cause local burns in animals, typically resulting from prolonged exposure of body parts or sparks from old x-ray tubes. It is important to note that the frequency of injury to veterinary staff and veterinarians is significantly lower than that in human medicine, highlighting the safety of diagnostic radiation in veterinary practice. In veterinary medicine, fewer images are taken compared to human medicine, particularly fewer CT scans. However, due to the manual restraint of animals to avoid anesthesia, at least one person is present in the control area, resulting in significantly higher radiation exposure than that of human medical staff. It is important to note that since the 1970s, dosimeters have been used to measure the radiation exposure of veterinary personnel, ensuring their safety. Feline hyperthyroidism (overactive thyroid) is a common disease in older cats. Radioiodine therapy is considered by many authors to be the treatment of choice. Following the administration of radioactive iodine, cats are kept in an isolation pen. The cat's radioactivity is measured to determine the time of discharge, which is typically 14 days after the start of therapy. The therapy requires significant radiation protection measures and is currently only offered at two veterinary facilities in Germany (as of 2010).
== Achievements == George Kenner contributed to many areas of organic chemistry. In the 1960s, George Kenner, R.A. Gregory and Hilda Tracy were involved in the seminal discovery and synthesis of the peptide hormone gastrin at the University of Liverpool. Gastrin is involved in secretion of gastric acid (HCl) in the stomach. The first chemical synthesis of a lysozyme-like enzyme of 129 amino acids using the classical approach was attempted by Kenner and his group at the University of Liverpool in the 1970s. This would have been the largest protein molecule synthesised in a laboratory using classical peptide synthesis up to that time. He carefully planned a convergent synthesis of this lysozyme analogue, containing 129 amino acid residues joined in a rigorously defined order. The efforts of Kenner and his group led to the synthesis of the 129 amino acid peptide chain in protected form. But the dream of making a wholly synthetic lysozyme enzyme was only achieved 30 years later, in 2007. This synthesis of functionally active lysozyme was achieved by a single individual, Thomas Durek, working in Steve B. Kent's group at the University of Chicago. The value of George Kenner's contributions to the methodology of peptide chemistry had profound influence on developments in many biomedicine fields. For example it led to the synthesis of antigens of defined geometry for immunological studies.
Sources: en.wikipedia.org
The plasma half-life or half life of elimination is the time required to eliminate 50% of the absorbed dose of a drug from an organism. Or put another way, the time that it takes for the plasma concentration to fall by half from its maximum levels.
=== Pakistan === The 2012 Pakistan fake medicine crisis revealed the scale of production of counterfeit medications in Pakistan. Over 100 heart patients died after administration of adulterated drugs by the Punjab Institute of Cardiology. Pakistan did not have any regulatory enforcement on production of medicines until this crisis occurred. In response to the crisis, a regulatory body was finally set up in February 2012.
Somatostatin receptor antagonists (or somatostatin inhibitors) are a class of chemical compounds that work by imitating the structure of the neuropeptide somatostatin, which is an endogenous hormone found in the human body. The somatostatin receptors are G protein-coupled receptors. Somatostatin receptor subtypes in humans include sstr1, 2A, 2 B, 3, 4, and 5. While normally expressed in the gastrointestinal (GI) tract, pancreas, hypothalamus, and central nervous system (CNS), they are expressed in different types of tumours. The predominant subtype in cancer cells is the ssrt2 subtype, which is expressed in neuroblastomas, meningiomas, medulloblastomas, breast carcinomas, lymphomas, renal cell carcinomas, paragangliomas, small cell lung carcinomas, and hepatocellular carcinomas. As a radiopharmaceutical compound that is selective for somatostatin receptors, there is research being done for these radiolabeled compounds to act as diagnostic tests in PET scans for neuroendocrine tumors and other tumors not previously targeted with radiolabeled somatostatin receptor agonists, and to act as radiopharmaceutical therapeutic compound, more specifically to conduct peptide radionuclide receptor therapy. Some non-radiopharmaceutical compounds that are developed as competitive inhibitors of somatostatin, such as the hormone antagonist cyclosomatostatin.
=== Cot–Cz === Frank Albert Cotton (1930–2007), American chemist known for research on transition metals and as coauthor of Advanced Inorganic Chemistry, 2000 Wolf Prize in Chemistry Charles Coulson (1910–1974), British theoretical chemist, pioneer of the application of quantum theory to problems of molecular structure Archibald Scott Couper (1831–1892), British chemist who developed the concept of tetravalent carbon atoms linking together to form large molecules James Crafts (1839–1917), American chemist, developer of Friedel–Crafts reaction for alkylation and acylation Donald J. Cram (1919–2001), American chemist, winner of the 1987 Nobel Prize in Chemistry for development of molecules with structure-specific interactions of high selectivity William Crookes (1832–1919), British chemist who discovered thallium, and was a pioneer of vacuum tubes Alexander Crum Brown (1838–1922), Scottish organic chemist who developed the concept of tetravalent carbon atoms linking together to form large molecules Paul J.
While accepting an Honorary César in February 2026, Carrey revealed that he was in a long-term relationship with a woman named Min Ah, whom he called his "sublime companion." Seven months later, the couple were married in a private ceremony.
Sources: en.wikipedia.org
== Deaths == 3 January – Derek Draper, 56, lobbyist and political adviser. 15 January – James Masih Shera, 77, Pakistani-born British politician and educationist. 17 January – Sir Tony Lloyd, 73, British politician, MP (1983–2012, since 2017) and mayor of Greater Manchester (2015–2017), leukemia. 19 January – Sir Graham Bright, 81, British politician, MP (1979–1997) and Cambridgeshire police and crime commissioner (2012–2016). 20 January – John Tomlinson, Baron Tomlinson, 84, British politician, MP (1974–1979) and MEP (1984–1999). 6 February – Shreela Flather, Baroness Flather, 89, British-Indian politician, Life peer (since 1990). 23 February – Ronnie Campbell, 80, British politician, MP (1987–2019). 25 February – Patrick Cormack, Baron Cormack, 84, British politician, MP (1970–2010) and member of the House of Lords (since 2010). (death announced on this date) 26 February – Jacob Rothschild, 4th Baron Rothschild, 87, British investment banker and peer, member of the House of Lords (1991–1999). 29 February – Ruth Henig, Baroness Henig, 80, historian and politician, member of the House of Lords (since 2004), Deputy Speaker of the House of Lords (since 2018). 8 March – Tommy McAvoy, Baron McAvoy, 80, British politician, MP (1987–2010) and member of the House of Lords (since 2010). (death announced on this date) 6 April – Doug Hoyle, Baron Hoyle, 98, British politician, MP (1974–1979, 1981–1983) and member of the House of Lords (1997–2023). 10 April – Richard Rosser, Baron Rosser, 79, British trade unionist and politician, member of the House of Lords (since 2004).
=== Tobacco === Polonium-210 in tobacco contributes to many of the cases of lung cancer worldwide. Most of this polonium is derived from lead-210 deposited on tobacco leaves from the atmosphere; the lead-210 is a product of radon-222 gas, much of which appears to originate from the decay of radium-226 from fertilizers applied to the tobacco soils. The presence of polonium in tobacco smoke has been known since the early 1960s. Some of the world's biggest tobacco firms researched ways to remove the substance—to no avail—over a 40-year period. The results were never published.
To develop organisms with novel or enhanced characteristics, this emerging field of study combines biology, engineering, and related disciplines' knowledge and techniques to design chemically synthesized DNA. Biomolecular engineering includes approaches that aim to create a toolkit of functional units that can be introduced to present new technological functions in living cells. Genetic engineering includes approaches to construct synthetic chromosomes or minimal organisms like Mycoplasma laboratorium. Biomolecular design refers to the general idea of de novo design and additive combination of biomolecular components. Each of these approaches shares a similar task: to develop a more synthetic entity at a higher level of complexity by inventively manipulating a simpler part at the preceding level. Optimizing these exogenous pathways in unnatural systems takes iterative fine-tuning of the individual biomolecular components to select the highest concentrations of the desired product. On the other hand, "re-writers" are synthetic biologists interested in testing the irreducibility of biological systems. Due to the complexity of natural biological systems, it would be simpler to rebuild the natural systems of interest from the ground up; to provide engineered surrogates that are easier to comprehend, control and manipulate. Re-writers draw inspiration from refactoring, a process sometimes used to improve computer software.
Charlotte Dacre (1771 or 1772 – 7 November 1825) English author of Gothic novels; wrote under the pseudonym "Rosa Matilda" to confuse her critics; her work was admired by some of the literary giants of her day and her novels influenced Percy Bysshe Shelley, who thought highly of her style and creative skills. Ellen Dahrendorf, Baroness Dahrendorf (née Ellen Joan Krug), author, historian, translator of Russian political works; former wife (1980–2004) of the late German/British academic and politician Ralf Dahrendorf; has served on the boards of Article 19, the Jewish Institute for Policy Research; has been chair of British branch of the New Israel Fund; was co-founder of the Working Group on the Internment of Dissidents in Psychiatric Hospitals; is a signatory of the Independent Jewish Voices declaration, which is critical of Israeli policies towards the Palestinians. Aviva Dautch (born 5 May 1978) poet, academic, curator and magazine publisher, of Eastern European ancestry; writer in residence at the British Museum, the Jewish Museum London and the Separated Child Foundation and is resident expert on BBC Radio 4's poetry series On Form; English co-translator for Afghan refugee poet and BBC World Service journalist Suhrab Sirat; has written articles, and curated exhibitions and events for arts organisations including the Bethlem Museum of the Mind, The British Library, The Royal Academy of Arts and Tara Arts;lectures internationally on Jewish arts and culture. In 2020 she was appointed executive director of Jewish Renaissance magazine.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.